Veterinary Infectious Disease Diagnostics Market Set to Grow to USD 6.88 Billion by 2036, with IDEXX Laboratories, Zoetis and Thermo Fisher
The global veterinary
infectious disease diagnostics market is projected to increase from USD
2.88 billion in 2026 to USD 6.88 billion by 2036, expanding at a compound
annual growth rate (CAGR) of 9.1% during the forecast period, according to
Fact.MR. The market was valued at approximately USD 2.64 billion in 2025.
Growing attention to animal health, the need for timely disease detection and
expanding diagnostic capabilities across livestock and companion animal care
are supporting market demand.
Veterinary infectious disease diagnostics help identify
viral, bacterial, parasitic and fungal infections in animals. Diagnostic kits,
PCR systems, immunoassays and laboratory testing solutions support
veterinarians and animal-health professionals in detecting pathogens and
monitoring disease outbreaks. These technologies also play a role in livestock
health management, food safety monitoring and veterinary research.
Get detailed market
forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=12266
Market Snapshot
- Market
value (2025): USD 2.64 billion
- Estimated
market value (2026): USD 2.88 billion
- Forecast
value (2036): USD 6.88 billion
- CAGR
(2026–2036): 9.1%
- Leading
product segment: Diagnostic Kits and Reagents
- Leading
animal type: Livestock Animals, with 42.1% share in 2026
- Leading
disease segment: Viral Infections
- Leading
technology: Molecular Diagnostics
- Leading
application: Clinical Diagnostics
Diagnostic Kits and Reagents Anchor Product Demand
Diagnostic kits and reagents are expected to lead the
product segment in 2026. Their broad use across veterinary testing environments
supports demand from veterinary clinics, diagnostic laboratories and livestock
operations. PCR test kits, immunoassay kits, rapid test kits and culture media
serve different testing requirements, depending on the pathogen and the
intended diagnostic workflow.
Molecular diagnostics are projected to lead the technology
segment. PCR and real-time PCR methods help detect pathogen-specific genetic
material, supporting the identification of infectious diseases.
Immunodiagnostic methods, microbiology testing and next-generation diagnostic
technologies also contribute to the market.
Livestock animals are expected to account for 42.1% of
animal-type demand in 2026. Cattle, poultry, swine, sheep and goats require
disease surveillance to support herd health and reduce the risk of infection
spreading across farms. Companion animal testing and aquaculture diagnostics
provide additional opportunities for diagnostic suppliers.
Disease Surveillance and Clinical Testing Expand
Application Opportunities
Viral infections are projected to lead the disease segment,
with testing needs spanning foot-and-mouth disease, rabies and avian influenza.
Bacterial infections, including tuberculosis, salmonellosis and leptospirosis,
also require reliable diagnostic methods.
Clinical diagnostics are expected to lead the application
segment. Routine screening and disease detection help veterinary professionals
identify infections and inform treatment or control measures. Diagnostic
solutions also support research and development, vaccine development, food
safety monitoring and epidemiological surveillance.
Regional Outlook: India Leads Country-Level Growth
India is projected to register the highest country-level
CAGR at 11% through 2036. Expanding veterinary healthcare access and increasing
attention to animal disease detection are supporting the country's growth
outlook.
China is forecast to grow at a 10.2% CAGR, supported by
investment in animal-health infrastructure and domestic diagnostic
capabilities. Brazil is expected to record a 9.6% CAGR, while the United States
is projected to expand at 8.9%. South Africa is forecast to register an 8.2%
CAGR, followed by Germany at 7.8% and Japan at 7.4%.
Competitive Landscape
The veterinary infectious disease diagnostics market
includes diagnostic technology providers, animal-health companies and
specialized testing businesses. Key companies profiled by Fact.MR include IDEXX
Laboratories Inc., Zoetis Services LLC, Thermo Fisher Scientific Inc., Virbac,
bioMérieux SA, IDvet, Neogen Corporation, Agrolabo S.p.A., Bio-Rad Laboratories
Inc. and Antech Diagnostics Inc.
IDEXX Laboratories holds an established position through its
veterinary diagnostic portfolio and commercial infrastructure. Zoetis
participates in animal health and diagnostic-related solutions, while Thermo
Fisher Scientific brings laboratory testing technologies and related
capabilities. Virbac and bioMérieux serve veterinary and diagnostic markets
through their respective product portfolios.
Fact.MR describes the competitive landscape as moderately
fragmented, with IDEXX Laboratories accounting for approximately 21% of global
market share. Competition is shaped by diagnostic accuracy, test availability,
technology capabilities, geographic reach and distribution networks. Suppliers
that provide reliable testing solutions across livestock and companion animal
segments can address a wider range of veterinary diagnostic requirements.
To View Related Reports
https://afgbfh.blogspot.com/2026/11/lithium-mining-market-set-to-grow-to.html
https://sportgalax.com/read-blog/27010
About Fact.MR
Fact.MR is a market research and competitive intelligence
provider delivering market intelligence, competitive analysis, and forecasting
across global industries. Its research helps businesses evaluate market demand,
understand competitive developments, and identify growth opportunities. Its
research methodology draws on 120+ secondary sources, benchmarks 65+ company
portfolios and incorporates more than 25 primary interviews.